636 results on '"Philipson, Tomas"'
Search Results
2. The Long-Run Growth in Obesity as a Function of Technological Change
3. The aggregate value of cancer screenings in the United States: full potential value and value considering adherence
4. The Value of Medical Innovation Versus Industry Rewards
5. Economic Epidemiology
6. Entry and Competition in Generic Biologics [with Commentary]
7. A Primer on the Economics of Re-Importation of Prescription Drugs [with Commentary]
8. Product Differentiation, Competition and Regulation of New Drugs: The Case of Statins in Four European Countries [with Commentary]
9. Welfare-Enhancing Technological Change and the Growth of Obesity
10. The Quantity and Quality of Life and the Evolution of World Inequality
11. Association Between Breast Cancer Disease Progression and Workplace Productivity in the United States
12. Real-World Data : Policy Issues Regarding their Access and Use
13. Real-World Data : Responses to Zito and Doshi
14. Pricing and R&D When Consumption Affects Longevity
15. The Rise in Old-Age Longevity and the Market for Long-Term Care
16. Data Markets, Missing Data, and Incentive Pay
17. The Impact of Public Testing for Human Immunodeficiency Virus
18. Longevity Complementarities under Competing Risks
19. An Empirical Examination of Information Barriers to Trade in Insurance
20. Subject Evaluation in Social Experiments
21. Experiments and Subject Sampling
22. Disease Eradication: Private versus Public Vaccination
23. Data Markets and the Production of Surveys
24. The Responsiveness of the Demand for Condoms to the Local Prevalence of AIDS
25. The Economic Epidemiology of Crime
26. Rational Epidemics and Their Public Control
27. Private Vaccination and Public Health: An Empirical Examination for U.S. Measles
28. FINANCIAL HEALTH ECONOMICS
29. The Economic Value and Pricing of Personalized Medicine
30. The Value of Medical Innovation Versus Industry Rewards
31. Defining Value: The Need for a Longer, Broader View
32. Economic Burden of Disease-Associated Malnutrition in China
33. Endogenous cost-effectiveness analysis and health care technology adoption
34. Labor Supply and Weight
35. Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets
36. Altruism and Innovation in Health Care
37. Antitrust in the Not‐for‐Profit Sector
38. Is the Food and Drug Administration Safe and Effective?
39. The impact of comparative effectiveness research on health and health care spending
40. Integrated Insurance Design in the Presence of Multiple Medical Technologies
41. Health, Wealth, and the 21st Century Cures Act
42. 11. Economic Issues Associated with Incorporating Cost-Effectiveness Analysis into Public Coverage Decisions in the United States - Anupam B. Jena and Tomas J. Philipson
43. The Bayesian Model of Conditional Preference and Trade Under Uncertainty
44. An economic evaluation of the war on cancer
45. The Dual Effects of Intellectual Property Regulations: Within‐ and Between‐Patent Competition in the U.S. Pharmaceuticals Industry *
46. The Regulation of Medical Innovation and Pharmaceutical Markets *
47. Sharing R&D Risk in Healthcare via FDA Hedges
48. Managed Care and the Quality of Health Care: A Misguided Debate?
49. Managing risk in drug development: the case for FDA swaps and annuities
50. Clinical evidence inputs to comparative effectiveness research could impact the development of novel treatments
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.